IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The company was founded in 2016 through the merger of Quintiles and IMS Health and is headquartered in Durham, North Carolina.
IQVIA offers a wide range of services and solutions that help pharmaceutical, biotechnology, and medical device companies in their drug development and commercialization efforts. This includes clinical research services, such as clinical trial design, patient recruitment, and data management, as well as consulting services that provide strategic insights and market intelligence to support clients' business decisions.
In addition to its research and development services, IQVIA offers technology solutions that enable life sciences companies to optimize their operations and improve patient outcomes. These solutions involve advanced data analytics, real-world evidence analysis, and digital health technologies that enhance clinical trial processes, optimize supply chains, and enable personalized healthcare.
IQVIA went public in 2017, with its shares listed on the New York Stock Exchange under the ticker symbol "IQV." The IPO marked a significant milestone for the company, providing it with increased financial resources to support its growth and expansion plans.
As a global leader in the life sciences industry, IQVIA plays a vital role in advancing healthcare innovation and improving patient outcomes. The company's comprehensive suite of services and solutions enables its clients to navigate the complex and highly regulated landscape of the pharmaceutical industry, accelerate the development of new therapies, and bring them to market more efficiently.